ARX Sciences

Executive Summary

ARX Sciences is a San Diego-based private supplier of high-quality antibodies and proteins, founded in 2018. The company offers a wide range of primary and secondary antibodies validated for applications such as ELISA, Western blot, IHC, IP, and IF. With a focus on purity and quality, ARX Sciences serves the research community, but its small scale and lack of disclosed funding or partnerships suggest a niche market position. The company's limited public profile and absence of major commercial or regulatory milestones indicate a need for further growth and market penetration to become a significant player in the competitive antibody space.

Upcoming Catalysts (preview)

• Q4 2026Expansion of product portfolio into novel antibody formats60% success
• Q2 2027Strategic partnership or distribution agreement with a major life science distributor40% success
• Q1 2027Series A funding round to scale operations and R&D50% success